Solid Biosciences Inc. - stock earnings
SLDB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -20.3 million USD | ? USD |
| 2023Q3 | -21.0 million USD | ? USD |
| 2023Q2 | -24.6 million USD | ? USD |
| 2023Q1 | -28.1 million USD | ? USD |
| 2022Q4 | 4.6 million USD | 8.1 million USD |
| 2022Q3 | -19.7 million USD | ? USD |
| 2022Q2 | -24.8 million USD | 6.2 million USD |
| 2022Q1 | -25.3 million USD | 1.9 million USD |
| 2021Q4 | -18.6 million USD | 3.2 million USD |
| 2021Q3 | -18.0 million USD | 3.5 million USD |
| 2021Q2 | -18.7 million USD | 3.6 million USD |
| 2021Q1 | -16.9 million USD | 3.3 million USD |
| 2020Q4 | -21.4 million USD | ? USD |
| 2020Q3 | -21.2 million USD | ? USD |
| 2020Q2 | -19.0 million USD | ? USD |
| 2020Q1 | -26.7 million USD | ? USD |
| 2019Q4 | -31.9 million USD | ? USD |
| 2019Q3 | -29.3 million USD | ? USD |
| 2019Q2 | -26.5 million USD | ? USD |
| 2019Q1 | -29.6 million USD | ? USD |
| 2018Q4 | -21.9 million USD | ? USD |
| 2018Q3 | -19.0 million USD | ? USD |
| 2018Q2 | -18.0 million USD | ? USD |
| 2018Q1 | -15.9 million USD | ? USD |
| 2017Q4 | -14.5 million USD | ? USD |
| 2017Q3 | -13.5 million USD | ? USD |
| 2017Q2 | -11.3 million USD | ? USD |
| 2017Q1 | -12.8 million USD | ? USD |
| 2016Q4 | -7.8 million USD | ? USD |
| 2015Q4 | -6.4 million USD | ? USD |
SLDB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -96.0 million USD | ? USD |
| 2022 | -65.5 million USD | 8.1 million USD |
| 2021 | -72.1 million USD | 13.6 million USD |
| 2020 | -90.1 million USD | 3.3 million USD |
| 2019 | -115.6 million USD | ? USD |
| 2018 | -74.8 million USD | ? USD |
| 2017 | -52.1 million USD | ? USD |
| 2016 | -21.5 million USD | ? USD |
| 2015 | -6.4 million USD | ? USD |
SLDB
Price: $10.10
52 week price:
Earnings Per Share: -4.83 USD
P/E Ratio: 0.10
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 27300
Market Capitalization: 378.9 million